Women's Health Medicine
Volume 3, Issue 5 , Pages 213-216, 1 September 2006

Hormone replacement therapy – the agents

  • Göran Samsioe, MD

      Affiliations

    • Göran Samsioe MD is Professor of Gynecological Endocrinology at the Department of Obstetrics and Gynaecology at Lund University Hospital, Sweden
  • ,
  • Martina Dören, MD

      Affiliations

    • Martina Dören MD is Professor at the Free University of Berlin, and affiliated with the Benjamin Franklin University Hospital, Head of the Clinical Research Center of Women’s Health in Berlin, Germany
  • ,
  • Rogerio A Lobo, MD

      Affiliations

    • Rogerio A Lobo MD is Professor at the Department of Obstetrics and Gynaecology, Columbia University College of Physicians & Surgeons, Columbia Presbyterian Medical Center, New York, USA

Abstract 

Hormone Therapy (HT) is a valid option for women with climacteric symptoms. At present there is a controversy as to whether HT should be used chronically for prevention to each patient. This review investigates the basic use of oestrogens, progestogens, the HT regimens, bleeding problems in HT users and when HT is necessary.

Keywords:  hormone therapy , oestrogens , progestogens , bleeding

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 9.95 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

 This article has been reprinted from: Göran Samsioe, Martina Dören and Rogerio A Lobo. Rapid Reference to the Menopause. Oxford: Mosby, 2004.

PII: S1744-1870(06)70207-4

doi:10.1053/S1744-1870(06)70207-4

Women's Health Medicine
Volume 3, Issue 5 , Pages 213-216, 1 September 2006